|
MEX3C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.438800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.725800E-01 |
| Normal-vs-Stage2 |
6.877400E-01 |
| Normal-vs-Stage3 |
5.525200E-01 |
| Normal-vs-Stage4 |
8.856000E-01 |
| Stage1-vs-Stage2 |
9.090200E-01 |
| Stage1-vs-Stage3 |
2.232800E-01 |
| Stage1-vs-Stage4 |
8.318000E-01 |
| Stage2-vs-Stage3 |
4.090200E-01 |
| Stage2-vs-Stage4 |
8.970800E-01 |
| Stage3-vs-Stage4 |
6.460400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.591000E-01 |
| Normal-vs-AfricanAmerican |
6.667000E-01 |
| Normal-vs-Asian |
2.190800E-01 |
| Caucasian-vs-AfricanAmerican |
8.228600E-01 |
| Caucasian-vs-Asian |
4.682400E-01 |
| AfricanAmerican-vs-Asian |
4.350400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.007600E-01 |
| Normal-vs-Female |
1.923000E-01 |
| Male-vs-Female |
1.155650E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.110000E-01 |
| Normal-vs-Extreme_Weight |
2.491800E-01 |
| Normal-vs-Obese |
6.728800E-01 |
| Normal-vs-Extreme_Obese |
8.443400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.522400E-01 |
| Normal_Weight-vs-Obese |
5.352400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.927000E-01 |
| Extreme_Weight-vs-Obese |
1.135350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.701000E-01 |
| Obese-vs-Extreme_Obese |
6.892000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.798200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.291000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.112400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.294300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.240200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.440400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.285000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.597080E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.028400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.918000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.523400E-01 |
| Normal-VS-Type2 PRCC |
7.366200E-02 |
| Normal-VS-KIRP CIMP |
1.009990E-04 |
| Normal-VS-Unclassified PRCC |
9.049600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.491800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.374980E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.189200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.58740000000268E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.398040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.400000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.414000E-02 |
| Normal-vs-N1 |
1.564980E-01 |
| Normal-vs-N2 |
8.601800E-01 |
| N0-vs-N1 |
9.456000E-03 |
| N0-vs-N2 |
3.125600E-01 |
| N1-vs-N2 |
6.073800E-01 |
|
|
